Physical activity, return to work self-efficacy, and work status among employees undergoing chemotherapy for cancer - a prospective study with 12 months follow-up.
Cancer
Physical activity
Return to work
Self-efficacy
Work status
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
17 Feb 2021
17 Feb 2021
Historique:
received:
07
04
2020
accepted:
20
01
2021
entrez:
18
2
2021
pubmed:
19
2
2021
medline:
7
9
2021
Statut:
epublish
Résumé
Numerous studies emphasize the positive effects of physical activity on health and well-being in cancer patients. The effects of physical activity on the working lives of cancer patients have received less attention. The aim of the present study was to examine the association between physical activity and work status in employees with cancer, and the mediating role of return to work self-efficacy (RTWSE) in this association. Data from questionnaires (physical activity, RTWSE, performance status, sociodemographic), patient records, and Danish national registries (work status, education) were collected for 217 employees initiating chemotherapy for cancer. The associations of physical activity at baseline with work status at baseline and at twelve months follow-up, respectively, were estimated with logistic regression. The mediating role of RTWSE was investigated using the Sobel Goodmann test. Employees with moderate (> 30 min/day) or high (> 150 min/day) levels of current daily activity at baseline had significantly increased odds for working at baseline (OR = 2.83, 95%CI = 0.73-10.96 and OR = 6.13, 95%CI = 1.68-22.40, respectively) and at twelve months (OR = 3.90, 95%CI = 1.19-12.77 and OR = 3.43, 95%CI = 1.12-10.51, respectively), compared to sedentary employees. Likewise, employees, physically active in their leisure time (light or vigorous psychical activity) for 2-4 h/week or > 4 h/week of light activity at baseline, had increased odds for working at twelve months (OR range = 1.20 (95%CI = 0.40-3.61)-5.39(95%CI = 0.78-37.32)), compared to sedentary employees. RTWSE was not found to mediate the observed associations. Physical activity appears positively associated with work status in employees undergoing treatment for cancer in the twelve months period after initiating chemotherapy.
Sections du résumé
BACKGROUND
BACKGROUND
Numerous studies emphasize the positive effects of physical activity on health and well-being in cancer patients. The effects of physical activity on the working lives of cancer patients have received less attention. The aim of the present study was to examine the association between physical activity and work status in employees with cancer, and the mediating role of return to work self-efficacy (RTWSE) in this association.
METHODS
METHODS
Data from questionnaires (physical activity, RTWSE, performance status, sociodemographic), patient records, and Danish national registries (work status, education) were collected for 217 employees initiating chemotherapy for cancer. The associations of physical activity at baseline with work status at baseline and at twelve months follow-up, respectively, were estimated with logistic regression. The mediating role of RTWSE was investigated using the Sobel Goodmann test.
RESULTS
RESULTS
Employees with moderate (> 30 min/day) or high (> 150 min/day) levels of current daily activity at baseline had significantly increased odds for working at baseline (OR = 2.83, 95%CI = 0.73-10.96 and OR = 6.13, 95%CI = 1.68-22.40, respectively) and at twelve months (OR = 3.90, 95%CI = 1.19-12.77 and OR = 3.43, 95%CI = 1.12-10.51, respectively), compared to sedentary employees. Likewise, employees, physically active in their leisure time (light or vigorous psychical activity) for 2-4 h/week or > 4 h/week of light activity at baseline, had increased odds for working at twelve months (OR range = 1.20 (95%CI = 0.40-3.61)-5.39(95%CI = 0.78-37.32)), compared to sedentary employees. RTWSE was not found to mediate the observed associations.
CONCLUSIONS
CONCLUSIONS
Physical activity appears positively associated with work status in employees undergoing treatment for cancer in the twelve months period after initiating chemotherapy.
Identifiants
pubmed: 33596859
doi: 10.1186/s12885-021-07824-6
pii: 10.1186/s12885-021-07824-6
pmc: PMC7890631
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
169Subventions
Organisme : Kræftens Bekæmpelse
ID : R137-A8880-15-S3
Organisme : Oticon Fonden
ID : 16-1960
Références
Circulation. 1968 Dec;38(6):1104-15
pubmed: 5721960
Trials. 2013 Jun 14;14:175
pubmed: 23768153
BMJ. 2009 Oct 13;339:b3410
pubmed: 19826172
Acta Oncol. 2013 Jan;52(1):38-47
pubmed: 23106175
Scand J Public Health. 2011 Jul;39(7 Suppl):91-4
pubmed: 21775362
Support Care Cancer. 2017 Mar;25(3):709-718
pubmed: 27873016
J Occup Rehabil. 2015 Jun;25(2):423-31
pubmed: 25354750
Scand J Work Environ Health. 2011 Mar;37(2):109-19
pubmed: 21203742
Scand J Work Environ Health. 2016 Jul 1;42(4):338-45
pubmed: 27158861
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Scand J Public Health. 2008 Mar;36(2):117-25
pubmed: 18519275
PLoS One. 2017 May 4;12(5):e0176872
pubmed: 28472084
Am J Epidemiol. 2007 Mar 15;165(6):710-8
pubmed: 17182981
Cancer. 2013 Jun 1;119 Suppl 11:2151-9
pubmed: 23695927
Chiropr Man Therap. 2016 Sep 08;24(1):32
pubmed: 27610218
Health Educ Behav. 2014 Dec;41(6):573-6
pubmed: 25156312
Disabil Rehabil. 2005 Nov 15;27(21):1269-81
pubmed: 16298930
Scand J Public Health. 2007;35(5):497-502
pubmed: 17852980
J Cancer Surviv. 2010 Dec;4(4):415-37
pubmed: 20945110
PM R. 2017 Sep;9(9S2):S347-S384
pubmed: 28942909
J Occup Rehabil. 2013 Jun;23(2):290-9
pubmed: 23124685
JAMA. 2009 Feb 18;301(7):753-62
pubmed: 19224752
Acta Oncol. 1993;32(1):15-21
pubmed: 8466758
J Occup Rehabil. 2020 Dec;30(4):665-678
pubmed: 32114672
Acta Oncol. 2015 May;54(5):609-17
pubmed: 25751760
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Med Sci Sports Exerc. 2009 Apr;41(4):935-46
pubmed: 19276838
Ann Behav Med. 2005 Oct;30(2):138-45
pubmed: 16173910
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Eur J Cancer Care (Engl). 2012 Sep;21(5):634-41
pubmed: 22320237
BMJ Open. 2017 Nov 28;7(11):e015860
pubmed: 29187408
J Occup Rehabil. 2017 Dec;27(4):547-558
pubmed: 27858198
Psychooncology. 2013 Apr;22(4):783-91
pubmed: 22451113
Psychooncology. 2009 Apr;18(4):369-76
pubmed: 19242921
Br J Sports Med. 2018 Oct;52(20):1311
pubmed: 29549149
Eur J Cancer Care (Engl). 2011 Mar;20(2):257-66
pubmed: 20649808
J Occup Rehabil. 2012 Jun;22(2):220-9
pubmed: 22081271
BMC Public Health. 2014;14 Suppl 3:S8
pubmed: 25437351
BMJ. 2015 Mar 06;350:h1286
pubmed: 25747413
Crit Rev Oncol Hematol. 2018 Feb;122:52-59
pubmed: 29458789
BMC Med. 2015 Oct 29;13:275
pubmed: 26515383
J Occup Rehabil. 2011 Sep;21(3):421-30
pubmed: 21279425
Neuropsychiatr Dis Treat. 2018 Feb 09;14:479-494
pubmed: 29445285
BMJ Open. 2017 Jun 15;7(6):e014746
pubmed: 28619770
Cochrane Database Syst Rev. 2015 Sep 25;(9):CD007569
pubmed: 26405010
J Cancer Surviv. 2018 Apr;12(2):169-177
pubmed: 29076003
Public Health Nutr. 2003 May;6(3):299-305
pubmed: 12740079
J Occup Rehabil. 2015 Dec;25(4):725-32
pubmed: 25990375
J Occup Rehabil. 2011 Jun;21(2):244-58
pubmed: 20865445
J Community Health Nurs. 2015;32(4):199-211
pubmed: 26529105
Eur J Epidemiol. 2008;23(5):311-22
pubmed: 18270796
Scand J Caring Sci. 2019 Jun;33(2):467-477
pubmed: 30664270
J Phys Act Health. 2014 Mar;11(3):654-64
pubmed: 23416716
J Cancer Surviv. 2013 Jun;7(2):237-46
pubmed: 23443319
J Rehabil Med. 2016 Jun 13;48(6):541-6
pubmed: 27243598
J Clin Oncol. 2015 Jun 10;33(17):1918-27
pubmed: 25918291
Int J Environ Res Public Health. 2019 Apr 14;16(8):
pubmed: 31014004
J Cancer Surviv. 2019 Apr;13(2):244-256
pubmed: 30912010
Psychooncology. 2014 May;23(5):481-92
pubmed: 24375630
Scand J Med Sci Sports. 2015 Dec;25 Suppl 4:119-25
pubmed: 26589125
Cancer Treat Rev. 2017 Jan;52:91-104
pubmed: 28006694
Med Sci Sports Exerc. 2007 Aug;39(8):1423-34
pubmed: 17762377